Justin Manalac

Case-Control Study of Individuals with Discrepant Nucleocapsid and Spike Protein SARS-CoV-2 IgG Results in the assessment of suspected multisystem

J. Zehnder, S. Boyd, L. Yang, 2021 .

SARS-CoV-2 Antibody Responses Correlate with Resolution of RNAemia But Are Short-Lived in Patients with Mild Illness

R. Tibshirani, N. Shah, K. Nadeau, 2020, medRxiv.

Defining the features and duration of antibody responses to SARS-CoV-2 infection associated with disease severity and outcome

R. Tibshirani, N. Shah, B. Narasimhan, 2020, Science Immunology.

Case-Control Study of Individuals with Discrepant Nucleocapsid and Spike Protein SARS-CoV-2 IgG Results

J. Zehnder, S. Boyd, B. Pinsky, 2021, Clinical chemistry.

Title: Case-Control Study of Individuals with Discrepant Nucleocapsid and Spike Protein SARS-CoV- 2 IgG Results Running Head: SARS-CoV-2 IgG Assay Comparison

Katharina, J. Zehnder, S. Boyd, 2021 .

Evaluation of Abbott anti-SARS-CoV-2 CMIA IgG and Euroimmun ELISA IgG/IgA assays in a clinical lab

L. Nguyen, Pratikkumar A. Patel, R. Shi, 2020, Clinica Chimica Acta.